Naringenin (NAR) and 8-prenylnaringenin (8-PN) reduce the developmental competence of porcine oocytes in vitro

Reproductive Toxicology

Volumn 49, Issue , 2014, Pages 1-11

  Solak, Kamila A ^a   Santos, Regiane R ^b   van den Berg, Martin ^a   Blaauboer, Bas J ^a   Roelen, Bernard A J ^b   van Duursen, Majorie B M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

8 Prenylnaringenin; Embryo development; Lipid droplets; Naringenin; Oocyte maturation

Indexed keywords

8-PRENYLNARINGENIN; FLAVANONE DERIVATIVE; NARINGENIN; 8 PRENYLNARINGENIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA;

ANIMAL; BLASTOCYST; CELL CULTURE; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GROWTH, DEVELOPMENT AND AGING; IN VITRO STUDY; OOCYTE; PHYSIOLOGY; PIG; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINDLE APPARATUS; TOXICITY; ANIMAL CELL; ARTICLE; CELL EXPANSION; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUMULUS CELL; CUMULUS OOPHORUS; CYP11A1 GENE; CYP19 GENE; DOWN REGULATION; FEMALE GENITAL SYSTEM; FEMALE SUBFERTILITY; GENE; HSD3B1 GENE; MEIOTIC SPINDLE; NONHUMAN; OOCYTE CLEAVAGE; OOCYTE MATURATION; REPRODUCTIVE TOXICITY; STAR GENE; TOXICITY TESTING;

ANIMALS; BLASTOCYST; CELLS, CULTURED; DIETARY SUPPLEMENTS; FEMALE; FLAVANONES; GENE EXPRESSION; IN VITRO TECHNIQUES; OOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINDLE APPARATUS; SWINE;

SUS;

EID: 84904512774     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2014.05.013     Document Type: Article

References (80)

1. Eichenlaub-Ritter U., Winterscheidt U., Vogt E., Shen Y., Tinneberg H.R., Sorensen R. 2-Methoxyestradiol induces spindle aberrations, chromosome congression failure, and nondisjunction in mouse oocytes. Biol Reprod 2007, 76:784-793.
2. Sagata N. Introduction: meiotic maturation and arrest in animal oocytes. Semin Cell Dev Biol 1998, 9:535-537.
3. Kaji E., Bornslaeger E.A., Schultz R.M. Inhibition of mouse oocyte cyclic AMP phosphodiesterase by steroid hormones: a possible mechanism for steroid hormone inhibition of oocyte maturation. J Exp Zool 1987, 243:489-493.
4. Barrett C.B., Powers R.D. Progestins inhibit murine oocyte meiotic maturation in vitro. J Exp Zool 1993, 265:231-239.
5. Mingoti G.Z., Garcia J.M., Rosa-e-Silva A.A. The effect of serum on in vitro maturation, in vitro fertilization and steroidogenesis of bovine oocytes co-cultured with granulosa cells. Braz J Med Biol Res 1995, 28:213-217.
6. Sirotkin A.V. Involvement of steroid hormones in bovine oocytes maturation in vitro. J Steroid Biochem Mol Biol 1992, 41(March (3-8)):855-858.
7. Pellicer A. Oestrogens and follicular and oocyte development. Hum Reprod Update 1997, 3:93-94.
8. Miyano T., Manabe N. Oocyte growth and acquisition of meiotic competence. Soc Reprod Fertil Suppl 2007, 63:531-538.
9. Eichenlaub-Ritter U., Shen Y., Tinneberg H.R. Manipulation of the oocyte: possible damage to the spindle apparatus. Reprod Biomed Online 2002, 5:117-124.
10. Eichenlaub-Ritter U. Ageing and aneuploidy in oocytes. Ernst Schering Res Found Workshop 2002, 41:111-136.
11. Malekinejad H., Schoevers E.J., Daemen I.J., Zijlstra C., Colenbrander B., Fink-Gremmels J., et al. Exposure of oocytes to the Fusarium toxins zearalenone and deoxynivalenol causes aneuploidy and abnormal embryo development in pigs. Biol Reprod 2007, 77:840-847.
12. Velasquez M.T., Bhathena S.J. Dietary phytoestrogens: a possible role in renal disease protection. Am J Kidney Dis 2001, 37:1056-1068.
13. Lissin L.W., Cooke J.P. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000, 35:1403-1410.
14. Bhathena S.J., Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002, 76:1191-1201.
15. Kronenberg F., Hughes C. Exogenous and endogenous estrogens: an appreciation of biological complexity. Menopause 1999, 6:4-6.
16. Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 1999, 84:2249-2252.
17. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
18. Hunter D.S., Hodges L.C., Vonier P.M., Fuchs-Young R., Gottardis M.M., Walker C.L. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res 1999, 59:3090-3099.
19. Jeong H.J., Shin Y.G., Kim I.H., Pezzuto J.M. Inhibition of aromatase activity by flavonoids. Arch Pharm Res 1999, 22:309-312.
20. van Meeuwen J.A., Nijmeijer S., Mutarapat T., Ruchirawat S., de Jong P.C., Piersma A.H., et al. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts-a comparative study. Toxicol Appl Pharmacol 2008, 228:269-276.
21. Huang Z., Fasco M.J., Kaminsky L.S. Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids. J Steroid Biochem Mol Biol 1997, 63:9-15.
22. Ghosal A., Satoh H., Thomas P.E., Bush E., Moore D. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna expressed human cytochrome P450. Drug Metab Dispos 1996, 24:940-947.
23. Zierau O., Gester S., Schwab P., Metz P., Kolba S., Wulf M., et al. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med 2002, 68:449-451.
24. Kretzschmar G., Zierau O., Wober J., Tischer S., Metz P., Vollmer G. Prenylation has a compound specific effect on the estrogenicity of naringenin and genistein. J Steroid Biochem Mol Biol 2010, 118:1-6.
25. Terao J., Mukai R. Prenylation modulates the bioavailability and bioaccumulation of dietary flavonoids. Arch Biochem Biophys 2014, pii: S0003-9861(14)00125-8. 10.1016/j.abb.2014.04.002.
26. Erlund I., Meririnne E., Alfthan G., Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 2001, 131:235-241.
27. Possemiers S., Heyerick A., Robbens V., De Keukeleire D., Verstraete W. Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbι conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem 2005, 53:6281-6288.
28. Coldham N.G., Sauer M.J. Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem Toxicol 2001, 39:1211-1224.
29. Rad M., Humpel M., Schaefer O., Schoemaker R.C., Schleuning W.D., Cohen A.F., et al. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br J Clin Pharmacol 2006, 62:288-296.
30. Hu M.L. Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. Chang Gung Med J 2011, 34:449-460.
31. Jung U.J., Kim H.J., Lee J.S., Lee M.K., Kim H.O., Park E.J., et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr 2003, 22:561-568.
32. Sehmisch S., Hammer F., Christoffel J., Seidlova-Wuttke D., Tezval M., Wuttke W., et al. Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med 2008, 74:794-801.
33. Bowe J., Li X.F., Kinsey-Jones J., Heyerick A., Brain S., Milligan S., et al. The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes. J Endocrinol 2006, 191:399-405.
34. Adgent M.A., Daniels J.L., Rogan W.J., Adair L., Edwards L.J., Westreich D., et al. Early-life soy exposure and age at menarche. Paediatr Perinat Epidemiol 2012, 26:163-175.
35. Kim J., Kim S., Huh K., Kim Y., Joung H., Park M. High serum isoflavone concentrations are associated with the risk of precocious puberty in Korean girls. Clin Endocrinol (Oxf) 2011, 75:831-835.
36. Kouki T., Kishitake M., Okamoto M., Oosuka I., Takebe M., Yamanouchi K. Effects of neonatal treatment with phytoestrogens, genistein and daidzein, on sex difference in female rat brain function: estrous cycle and lordosis. Horm Behav 2003, 44:140-145.
37. Strom B.L., Schinnar R., Ziegler E.E., Barnhart K.T., Sammel M.D., Macones G.A., et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA 2001, 286:807-814.
38. Larsen M.O., Rolin B. Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR J 2004, 45:303-313.
39. Schoevers E.J., Santos R.R., Colenbrander B., Fink-Gremmels J., Roelen B.A. Transgenerational toxicity of Zearalenone in pigs. Reprod Toxicol 2012, 34:110-119.
40. Schoevers E.J., Fink-Gremmels J., Colenbrander B., Roelen B.A. Porcine oocytes are most vulnerable to the mycotoxin deoxynivalenol during formation of the meiotic spindle. Theriogenology 2010, 74:968-978.
41. Schoevers E.J., Kidson A., Verheijden J.H., Bevers M.M. Effect of follicle-stimulating hormone on nuclear and cytoplasmic maturation of sow oocytes in vitro. Theriogenology 2003, 59:2017-2028.
42. Testerink N., van der Sanden M.H., Houweling M., Helms J.B., Vaandrager A.B. Depletion of phosphatidylcholine affects endoplasmic reticulum morphology and protein traffic at the Golgi complex. J Lipid Res 2009, 50:2182-2192.
43. Aardema H., Vos P.L., Lolicato F., Roelen B.A., Knijn H.M., Vaandrager A.B., et al. Oleic acid prevents detrimental effects of saturated fatty acids on bovine oocyte developmental competence. Biol Reprod 2011, 85:62-69.
44. Salustri A., Garlanda C., Hirsch E., De Acetis M., Maccagno A., Bottazzi B., et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development 2004, 131:1577-1586.
45. Sotoca A.M., Ratman D., van der Saag P., Strom A., Gustafsson J.A., Vervoort J., et al. Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol 2008, 112:171-178.
46. Huang Z., Wells D. The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. Mol Hum Reprod 2010, 10:715-725.
47. Sugiura K., Su Y.Q., Li Q., Wigglesworth K., Matzuk M.M., Eppig J.J. Estrogen promotes the development of mouse cumulus cells in coordination with oocyte-derived GDF9 and BMP15. Mol Endocrinol 2010, 24:2303-2314.
48. Kuppusamy U.R., Khoo H.E., Das N.P. Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem Pharmacol 1990, 40:397-401.
49. Moon S.H., Kim K.T., Lee N.K., HanY.S.Nah S.Y., Cho S.G., Park Y.S., et al. Inhibitory effects of naringenin and its novel derivatives on hyaluronidase. Food Sci Biotechnol 2009, 18:267-270.
50. Varani S., Elvin J.A., Yan C., DeMayo J., DeMayo F.J., Horton H.F., et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 2002, 16:1154-1167.
51. Duraikannu A., Perumal S. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res 2013, 19:763-770.
52. Kikuchi K., Ekwall H., Tienthai P., Kawai Y., Noguchi J., Kaneko H., et al. Morphological features of lipid droplet transition during porcine oocyte fertilisation and early embryonic development to blastocyst in vivo and in vitro. Zygote 2002, 10:355-366.
53. Tammela P., Laitinen L., Galkin A., Wennberg T., Heczko R., Vuorela H., et al. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles. Arch Biochem Biophys 2004, 425:193-199.
54. Bok S.H., Lee S.H., Park Y.B., Bae K.H., Son K.H., Jeong T.S., et al. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 1999, 129:1182-1185.
55. Borradaile N.M., Carroll K.K., Kurowska E.M. Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids 1999, 34:591-598.
56. Enders A.C., Hendrickx A.G., Binkerd P.E. Abnormal development of blastocysts and blastomeres in the rhesus monkey. Biol Reprod 1982, 26:353-366.
57. Longo F.J. Ultrastructural changes in rabbit eggs aged in vivo. Biol Reprod 1974, 11:22-39.
58. Hishinuma M., Nakata H., Urano K., Takahashi Y., Kanagawa H. Histochemical observations of lipid droplets and glycogen in mouse eggs with abnormal development. Jpn J Vet Res 1985, 33:145-149.
59. van Duursen M.B., Smeets E.E., Rijk J.C., Nijmeijer S.M., van den Berg M. Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model. Toxicol Appl Pharmacol 2013, 269:132-140.
60. Jefferson W.N., Padilla-Banks E., Newbold R.R. Disruption of the developing female reproductive system by phytoestrogens: genistein as an example. Mol Nutr Food Res 2007, 51:832-844.
61. Sanderson J.T., Hordijk J., Denison M.S., Springsteel M.F., Nantz M.H., van den Berg M. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci 2004, 82:70-79.
62. Rice S., Mason H.D., Whitehead S.A. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol 2006, 101:216-225.
63. Fuhr U., Klittich K., Staib A.H. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 1993, 35:431-436.
64. Guengerich F.P., Kim D.H. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 1990, 11:2275-2279.
65. Li F., Ye L., Lin S.M., Leung L.K. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7. Mol Cell Endocrinol 2011, 15:51-58.
66. Conley A., Corbin J., Smith T., Hinshelwood M., Liu Z., Simpson E. Porcine aromatases: studies on tissue-specific, functionally distinct isozymes from a single gene. J Steroid Biochem Mol Biol 1997, 61:407-413.
67. Simpson E.R., Clyne C., Rubin G., Boon W.C., Robertson K., Britt K., et al. Aromatase-a brief overview. Annu Rev Physiol 2002, 64:93-127.
68. Bovee T.F., Helsdingen R.J., Rietjens I.M., Kejer J., Hoogenboom R.L. Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, and green fluorescent protein: a comparison of different compounds with both receptor types. J Steroid Biochem Mol Biol 2004, 91:99-109.
69. Ruh M.F., Zacharewski T., Connor K., Howell J., Chen I., Safe S. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem Pharmacol 1995, 50:1485-1493.
70. Miksicek R.J. Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 1993, 44:37-43.
71. Babalola G.O., Shapiro B.H. Correlation of follicular steroid hormone profiles with ovarian cyclicity in sows. J Reprod Fertil 1988, 84:79-87.
72. Beker A.R., Colenbrander B., Bevers M.M. Effect of 17beta-estradiol on the in vitro maturation of bovine oocytes. Theriogenology 2002, 58:1663-1673.
73. Beker-van Woudenberg A.R., van Tol H.T., Roelen B.A., Colenbrander B., Bevers M.M. Estradiol and its membrane-impermeable conjugate (estradiol-bovine serum albumin) during in vitro maturation of bovine oocytes: effects on nuclear and cytoplasmic maturation, cytoskeleton, and embryo quality. Biol Reprod 2004, 70:1465-1474.
74. Hemachandra L.P., Madhubhani P., Chandrasena R., Esala P., Chen S.N., Main M., et al. Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A). Cancer Prev Res (Phila) 2012, 5:73-81.
75. Doostdar H., Burke M.D., Mayer R.T. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000, 144:31-38.
76. de Cremoux P., This P., Leclercq G., Jacquot Y. Controversies concerning the use of phytoestrogens in menopause management: bioavailability and metabolism. Maturitas 2010, 65:334-339.
77. Rowland I., Wiseman H., Sanders T., Adlercreutz H., Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Trans 1999, 27:304-308.
78. Silberberg M., Gil-Izquierdo A., Combaret L., Remesy C., Scalbert A., Morand C. Flavanone metabolism in healthy and tumor-bearing rats. Biomed Pharmacother 2006, 60:529-535.
79. Mullen W., Archeveque M.A., Edwards C.A., Matsumoto H., Crozier A. Bioavailability and metabolism of orange juice flavanones in humans: impact of a full-fat yogurt. J Agric Food Chem 2008, 56:11157-11164.
80. Bredsdorff L., Nielsen I.L., Rasmussen S.E., Cornett C., Barron D., Bouisset F., et al. Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from alpha-rhamnosidase-treated orange juice in human subjects. Br J Nutr 2010, 103:1602-1609.